0001236215-21-000015.txt : 20211129
0001236215-21-000015.hdr.sgml : 20211129
20211129093316
ACCESSION NUMBER: 0001236215-21-000015
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211119
FILED AS OF DATE: 20211129
DATE AS OF CHANGE: 20211129
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CIPRIANO JOHN
CENTRAL INDEX KEY: 0001282304
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11889
FILM NUMBER: 211453181
MAIL ADDRESS:
STREET 1: 8229 BOONE BLVD
STREET 2: SUITE 802
CITY: VIENNA
STATE: VA
ZIP: 22182
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CEL SCI CORP
CENTRAL INDEX KEY: 0000725363
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 840916344
STATE OF INCORPORATION: CO
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 8229 BOONE BLVD .
STREET 2: SUITE 802
CITY: VIENNA
STATE: VA
ZIP: 22182
BUSINESS PHONE: 7035069460
MAIL ADDRESS:
STREET 1: 8229 BOONE BLVD.
STREET 2: SUITE 802
CITY: VIENNA
STATE: VA
ZIP: 22182
FORMER COMPANY:
FORMER CONFORMED NAME: INTERLEUKIN 2 INC
DATE OF NAME CHANGE: 19880317
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2021-11-19
0
0000725363
CEL SCI CORP
CVM
0001282304
CIPRIANO JOHN
8229 BOONE BLVD
SUITE 802
VIENNA
VA
22182
0
1
0
0
Senior Vice President
Options
10.48
2021-11-19
4
A
0
50000
0.01
A
2031-11-18
Common Stock
50000
788827
D
Each option entitles the holder to purchase one share of the Company's common stock at a price of $10.48 per share. The stock options vest 100% upon the approval of the first marketing application for any pharmaceutical based upon the Company's Multikine technology in any of the USA, Canada, UK, Germany, France, Italy, Spain, Japan, or Australia. None of the options will be exercisable before November 19, 2022.
John Cipriano
2021-11-29